{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:42:25Z","timestamp":1793119345926,"version":"4.5.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010399","name":"European Society of Cataract and Refractive Surgeons","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postoperative endophthalmitis is a devastating complication of cataract surgery. Intracameral moxifloxacin has emerged as a promising prophylactic strategy due to its broad-spectrum properties and pre-formulated preparations. However, a robust synthesis of evidence from randomized controlled trials (RCTs) is needed to confirm its efficacy and safety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review and meta-analysis were conducted using evidence from PubMed, Scopus, Web of Science, and CENTRAL, including RCTs published up to August 2025. The primary outcome was the incidence of endophthalmitis, while secondary outcomes included endothelial cell count (ECC) and central corneal thickness (CCT). We pooled outcomes using risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs) using Stata (version 18).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of six RCTs involving 4,438 patients were included. Overall, one RCT demonstrated a low risk of bias, three RCTs raised some concerns, and two RCTs were assessed as having a high risk of bias. Intracameral moxifloxacin significantly reduced the incidence of postoperative endophthalmitis compared to the control group (\n                      <jats:italic>n<\/jats:italic>\n                      =\u202f5 RCTs, RR: 0.22, 95% CI [0.07, 0.77],\n                      <jats:italic>p<\/jats:italic>\n                      =\u202f0.02). A sensitivity analysis excluding studies with a high risk of bias demonstrated that the effect remained statistically significant (\n                      <jats:italic>n<\/jats:italic>\n                      =\u202f3 RCTs, RR: 0.183, 95% CI 0.038, 0.874,\n                      <jats:italic>p<\/jats:italic>\n                      =\u202f0.03), with no evidence of heterogeneity (\n                      <jats:italic>I<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      =\u202f0%,\n                      <jats:italic>p<\/jats:italic>\n                      =\u202f0.65). There was no significant difference between the moxifloxacin and control groups regarding postoperative changes in ECC (\n                      <jats:italic>n<\/jats:italic>\n                      =\u202f3 RCTs, MD: 22.17, 95% CI [\u22128.53, 52.88],\n                      <jats:italic>p<\/jats:italic>\n                      =\u202f0.16) or CCT (\n                      <jats:italic>n<\/jats:italic>\n                      =\u202f3 RCTs, MD: -0.03, 95% CI [\u22120.36, 0.31],\n                      <jats:italic>p<\/jats:italic>\n                      =\u202f0.88).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Prophylactic intracameral moxifloxacin significantly reduces the incidence of postoperative endophthalmitis following cataract surgery. This substantial protective benefit is achieved without evidence of compromised endothelial safety; however, safety conclusions are limited by the small number of patients assessed and should be interpreted with caution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic review registration<\/jats:title>\n                    <jats:p>\n                      The study was registered in the International Prospective Register of Systematic Reviews (PROSPERO) (ID: CRD420251144067),\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251144067<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2025.1704056","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:34:43Z","timestamp":1767854083000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Intracameral moxifloxacin for endophthalmitis prophylaxis after cataract surgery: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Ahmed","family":"Abu-Zaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M. H. E.","family":"Alkandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainab A. R.","family":"Hubail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mshari S.","family":"Alenezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deemah","family":"Alkandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashed A.","family":"Alasoosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danah Jamil","family":"Hammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulwahab Q.","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulwahab","family":"Alqallaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatmah S.","family":"Semairan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulwahab","family":"Alhumaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah M.","family":"Alharran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s41433-025-03745-x","article-title":"The future of cataract surgery","volume":"39","author":"O\u2019Brart","year":"2025","journal-title":"Eye"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e22003","DOI":"10.7759\/cureus.22003","article-title":"Postoperative endophthalmitis after cataract surgery: an update","volume":"14","author":"Althiabi","year":"2022","journal-title":"Cureus PubMed Cent"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/antibiotics12121670","article-title":"Management and prognosis of acute post-cataract surgery Endophthalmitis: A 10-year retrospective analysis in eastern China","volume":"12","author":"Zhang","year":"2023","journal-title":"Antibiotics"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.22608\/APO.2017200","article-title":"Endophthalmitis prophylaxis for cataract surgery","volume":"6","author":"Haripriya","year":"2017","journal-title":"Asia Pac J Ophthalmol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/ICL.0000000000001164","article-title":"Double povidone-iodine 5% preparation before cataract surgery for Endophthalmitis prevention","volume":"51","author":"Odden","year":"2025","journal-title":"Eye Contact Lens"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jcrs.2006.02.021","article-title":"ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery. Preliminary report of principal results from a European multicenter study","volume":"32","author":"Barry","year":"2006","journal-title":"J Cataract Refract Surg"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.17116\/oftalma2018134051104","article-title":"Complications of intracameral cefuroxime in cataract surgery","volume":"134","author":"Svetozarskiy","year":"2018","journal-title":"Vestn oftalmol"},{"key":"ref8","article-title":"Cefuroxime","volume-title":"StatPearls","author":"Omole","year":""},{"key":"ref9","volume-title":"Evidence Brief: Intracameral Moxifloxacin for Prevention of Endophthalmitis After Cataract Surgery","author":"Anderson","year":"2022"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.jcrs.2007.06.026","article-title":"Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin","volume":"33","author":"O\u2019Brien","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"ref11","first-page":"14","article-title":"Safety of prophylactic intracameral moxifloxacin during phacoemulsification","volume":"9","author":"Amer","year":"2013","journal-title":"J Am Sci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1136\/bmjophth-2020-000609","article-title":"Postoperative endophthalmitis with and without intracameral moxifloxacin prophylaxis in a high volume surgery setting","volume":"6","author":"Bhatta","year":"2021","journal-title":"BMJ Open Ophthalmol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ophtha.2017.01.026","article-title":"Endophthalmitis reduction with Intracameral moxifloxacin prophylaxis: analysis of 600\u202f000 surgeries","volume":"124","author":"Haripriya","year":"2017","journal-title":"Ophthalmology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.jcrs.2008.05.034","article-title":"Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery","volume":"34","author":"Lane","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"ref15","first-page":"3","article-title":"Comparison of post-operative endophthalmitis prophylaxis using intracameral cefuroxime and moxifloxacin in rural Pakistan-a randomized controlled trial","volume":"12","author":"Shakeel","year":"2020","journal-title":"Isra Med J."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.7869\/djo.218","article-title":"Effect of intracameral moxifloxacin (0.5mg) on morphology and cell density of corneal endothelium in phacoemulsification surgery","volume":"27","author":"Malik","year":"2016","journal-title":"Delhi J Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.21608\/ejomos.2022.89618.1028","article-title":"Safety of prophylactic intracameral moxifloxacin injection after uncomplicated phacoemulsification surgery","author":"Ashraf","year":"2022","journal-title":"Egypt J Ophthal"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jcrs.2018.10.044","article-title":"Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis: randomized controlled clinical trial","volume":"45","author":"Melega","year":"2019","journal-title":"J Cataract Refract Surg"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page","year":"2021","journal-title":"Syst Rev"},{"key":"ref20","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2023"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"Rating quality of evidence and strength of recommendations: what is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ Br Med J"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"Rating quality of evidence and strength of recommendations: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/biom.12817","article-title":"Quantifying publication bias in meta-analysis","volume":"74","author":"Lin","year":"2018","journal-title":"Biometrics"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0084-392X(08)79175-5","article-title":"Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors","volume":"2008","author":"Tipperman","year":"2008","journal-title":"Yearb Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2147\/OPTH.S59776","article-title":"Intracameral cefuroxime and moxifoxacin used as endophthalmitis prophylaxis after cataract surgery: systematic review of effectiveness and cost-effectiveness","volume":"8","author":"Linertov\u00e1","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1136\/bjophthalmol-2017-311051","article-title":"Comparative analysis of the safety and efficacy of intracameral cefuroxime, moxifloxacin and vancomycin at the end of cataract surgery: A meta-analysis","volume":"102","author":"Bowen","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/aos.12684","article-title":"Antibiotic prevention of postcataract endophthalmitis: A systematic review and meta-analysis","volume":"93","author":"Kessel","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jcrs.2012.07.031","article-title":"Decreased postoperative endophthalmitis rate after institution of intracameral antibiotics in a northern California eye department","volume":"39","author":"Shorstein","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ophtha.2015.09.037","article-title":"Efficacy of Intracameral moxifloxacin Endophthalmitis prophylaxis at Aravind eye hospital","volume":"123","author":"Haripriya","year":"2016","journal-title":"Ophthalmology"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.jcrs.2016.10.017","article-title":"Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis","volume":"42","author":"Arshinoff","year":"2016","journal-title":"J Cataract Refract Surg"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0002-9394(02)01334-X","article-title":"Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics","volume":"133","author":"Mather","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.2147\/OPTH.S411454","article-title":"Endothelial cell loss following cataract surgery using continuous curvilinear Capsulorhexis or precision pulse capsulotomy","volume":"17","author":"Vital","year":"2023","journal-title":"Clin Ophthalmol"},{"key":"ref35","first-page":"402","article-title":"Comparative analysis of endothelial cell loss in mature cataracts following phacoemulsification and manual small incision cataract surgery","volume":"32","author":"Mandal","year":"2025","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.jcrs.2008.03.017","article-title":"Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery","volume":"34","author":"Arbisser","year":"2008","journal-title":"J Cataract Refract Surg"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jcrs.2006.09.019","article-title":"Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients","volume":"33","author":"Espiritu","year":"2007","journal-title":"J Cataract Refract Surg"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1167\/iovs.05-0702","article-title":"Intravitreal moxifloxacin: retinal safety study with electroretinography and histopathology in animal models","volume":"47","author":"Gao","year":"2006","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ajo.2005.11.014","article-title":"Intracameral Vigamox\u00ae (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model","volume":"141","author":"Kodjikian","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1001\/archopht.124.4.479","article-title":"In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates","volume":"124","author":"Miller","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"e001935","DOI":"10.1136\/bmjophth-2024-001935","article-title":"Is there evidence for changes in antibiotic resistance of microorganisms causing postcataract surgery endophthalmitis: a systematic review","volume":"10","author":"Flaxel","year":"2025","journal-title":"BMJ Open Ophthalmol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.22336\/rjo.2021.25","article-title":"Preoperative antisepsis in ophthalmic surgery (a review)","volume":"65","author":"Zaharia","year":"2021","journal-title":"Rom J Ophthalmol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"503","DOI":"10.3390\/microorganisms11020503","article-title":"Broad-spectrum antimicrobial activity of Oftasecur and Visuprime ophthalmic solutions","volume":"11","author":"Dell'Annunziata","year":"2023","journal-title":"Microorganisms"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/jamaophthalmol.2013.2379","article-title":"Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection","volume":"131","author":"Yin","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s10384-021-00899-5","article-title":"Ocular surface flora and prophylactic antibiotics for cataract surgery in the age of antimicrobial resistance","volume":"66","author":"Iwasaki","year":"2022","journal-title":"Jpn J Ophthalmol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/aos.17469","article-title":"Evaluating the efficacy of postoperative topical antibiotics in cataract surgery: a systematic review and meta-analysis","volume":"103","author":"Passaro","year":"2025","journal-title":"Acta Ophthalmol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1704056\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:34:46Z","timestamp":1767854086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1704056\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":46,"alternative-id":["10.3389\/fmed.2025.1704056"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1704056","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]},"article-number":"1704056"}}